Table 2.

Intention to treat analysis of primary and secondary outcomes for a nationwide online randomized controlled trial to evaluate the impact of a crowdsourced intervention on hepatitis test uptake among men who have sex with men in China, 2018.

	Total		Intervention		Control
	(n = 556)		(n = 280)		(n = 276)
	No.	%	No.	%	No.	%	OR1	95% CI	OR2	95% CI
Primary Outcome
Confirmed HBV and HCV test uptake	44	7•9%	22	7•9%	22	8•0%	0•98	0•53–1•82	1•46	0•72–2•95
Secondary Outcomes
Self-reported HBV and HCV test uptake	97	17•4%	45	16•1%	52	18•8%	0•82	0•53–1•28	0•94	0•57–1•55
Confirmed HBV test uptake	48	8•6%	23	8•2%	25	9•1%	0•90	0•50–1•62	1•29	0•66–2•51
Confirmed HCV test uptake	44	7•9%	22	7•9%	22	8•0%	0•98	0•53–1•82	1•46	0•72–2•95
Self-reported HBV test uptake	124	22•3%	59	21•1%	65	23•6%	0•87	0•58–1•29	0•94	0•60–1•49
Self-reported HCV test uptake	103	18•5%	48	17•1%	55	19•9%	0•83	0•54–1•28	0•96	0•59–1•58
HBV vaccination uptake	39	7•0%	18	6•4%	21	7•6%	0•83	0•43–1•60	0•94	0•43–2•06
HIV test uptake	217	39•0%	114	40•7%	103	37•3%	1•15	0•82–1•62	1•41	0•95–2•08
Chlamydia test uptake	27	4•9%	14	5•0%	13	4•7%	1•06	0•49–2•31	1•36	0•62–2•96
Gonorrhea test uptake	35	6•3%	17	6•1%	18	6•5%	0•93	0•47–1•84	1•06	0•51–2•20
Syphilis test uptake	116	20•9%	62	22•1%	54	19•6%	1•17	0•78–1•76	1•44	0•90–2•30
Visit with a physician after hepatitis test	53	9•5%	27	9•6%	26	9•4%	1•03	0•58–1•81	1•07	0•55–2•05

1 Odds ratios with 95% confidence intervals for intention to treat analysis using a missing=failure approach to account for men lost to follow-up.

2 Odds ratios with 95% confidence intervals for intention to treat analysis using multiple imputation to account for men lost to follow-up.